The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Atovaquone/Proguanil Hydrochloride 250 mg /100 mg film-coated tablets

250/100 milligram(s) Film-coated tablet

Glenmark Pharmaceuticals Europe LimitedPA1462/016/001

Main Information

Trade NameAtovaquone/Proguanil Hydrochloride 250 mg /100 mg film-coated tablets
Active SubstancesAtovaquone
PROGUANIL HYDROCHLORIDE
Strength250/100 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderGlenmark Pharmaceuticals Europe Limited
Licence NumberPA1462/016/001

Group Information

ATC CodeP01BB Biguanides
P01BB51 proguanil, combinations

Status

Authorised/WithdrawnAuthorised
Licence Issued07/07/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back